주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요

Elsevier
엘스비어와 함께 출판

Embase Datasets for drug safety and pharmacovigilance

The most trusted biomedical literature for pharmacovigilance is now accessible via API.

Contact an Elsevier expert
Three pharma professionals discussing research findings in lab coats

Is your PV process effective?

Don't get left behind with your pharmacovigilance. Join the world's leading pharma and medical device companies in the switch to an AI-enabled process. Automate deduplication and train your models on better signal identification for a streamlined and revolutionary PV process.

Bring confidence to your ML-driven pharmacovigilance

Abstract gravity wave background - 3D rendered image.

Integrate Embase's gold-standard content with advanced AI to improve adverse event monitoring, better signal detection and streamlined pharmacovigilance workflows.

The world's leading source of biomedical and drug safety data

Two Female Scientists Working, Using Digital Tablet, Analysing Samples, Talking
  • Structured biomedical literature, extracted from 8.3k journals (including 3.3k not found in Medline)

  • Structured data extracted from FDA, EMA regulatory documents and literature articles

  • 2.8M extracted safety and adverse event data

Let's discuss your data needs for pharmacovigilance

Want to learn more about how the Embase API can integrate this trusted data into your automated workflows? Fill out the form below and an Elsevier expert will contact you soon to discuss how Embase Datasets can support your AI success.

본인에 대한 정보
소속 조직에 대한 정보
How does your organization intend to use the Elsevier data? *